Expansion of analytical capacities by 3P Biopharmaceuticals

Expansion of analytical capacities by 3P Biopharmaceuticals

3P Biopharmaceuticals has recently increased its analytical capacities and capabilities.

The 3P Analytical Development Area is one of the company’s core competences and is crucial to the state-of-the-art technologies as well as services it provides to the clients.

Expansion of analytical capacities by 3P Biopharmaceuticals

The development of analytical methods is an essential activity in any process development and manufacturing of biologics.

Analytical Development area is enjoying larger, more comfortable rooms. This expansion allowed 3P to optimise the daily activities as well as create the potential for further improvements.

In addition to area expansion 3P has made a great economic investment in state-of-the-art equipment and technology that increases its capabilities to support the Clients in various needs of analytical methods development, process development and manufacturing of biopharmaceuticals. 3P also offers analytical solutions in the late stages of the biopharmaceuticals´ development – process characterisation, which ensures successful entrance to the market.

Our dedicated team of specialists will be happy to discuss any of your analytical needs. Contact us on +34 948 346 480 or email withinus@3pbio.com

Related Content

Osivax and 3P Biopharmaceuticals team up to develop a new universal vaccine against current and future variants of SARS-COV-2

Osivax's novel oligoDOM® technology, designed to induce potent T-cell responses, will serve as the basis for this broad-spectrum vaccine against COVID-19
Read more

Elena Erroba, winner of the Navarra 2021 Management Award organised by AMEDNA-NEEZE

Elena Erroba, Director of Business Development, Communication and Marketing at 3P Biopharmaceuticals, has been elected as Navarra’s Businesswoman of the Year 2021
Read more

3P Biopharmaceuticals presents its growth plan at BIOSPAIN to further expand its operations in Europe and the USA

The investments will enable the company to increase its mammalian cell-based protein production capacity tenfold and increase its microbial cell-based protein production capacity by 50%. The total floor space of the company will triple.
Read more

Get in touch

Let’s discuss your biologics journey.

Discover more about our people, our passion, and how we can work together to improve lives.